TC BioPharm (Holdings) plc
TCBPDelisted Aug 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001872812
TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding TC BioPharm (Holdings) plc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 0 | 8 | +8 |
| Shares | 0 | 279.1K | +279.1K |
| Value | $0 | $399.0K | +$399.0K |
New holders (8)
Institutions that held TC BioPharm (Holdings) plc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kepos Capital LP | 184,757 | $264.0K | 0.02% |
| Citadel Advisors LLC | 22,379 | $32.0K | 0.00% |
| Two Sigma Securities, LLC | 20,859 | $30.0K | 0.00% |
| Susquehanna International Group, LLP | 17,305 | $25.0K | 0.00% |
| Virtu Financial LLC | 16,294 | $23.0K | 0.00% |
| Jane Street Group, LLC | 15,688 | $22.0K | 0.00% |
| UBS Group AG | 1,191 | $2.00K | 0.00% |
| Citigroup Inc | 600 | $1.00K | 0.00% |
Sold out (0)
Institutions that held TC BioPharm (Holdings) plc at the end of Q4 2021 and filed for Q1 2022 without it.
None.